investor lawsuit

Beyond Meat faces securities class action over alleged asset impairment misstatements; lead plaintiff deadline is March 24, 2026.

Rosen Law Firm files securities class action against Paysafe Limited, alleging false statements about business operations and financial performance. Investors must act before lead plaintiff deadline.

Securities class action filed against uniQure alleging FDA approval misrepresentations. April 13, 2026 deadline for lead plaintiff claims.

Securities class action filed against $PYPL for allegedly making false statements about 2027 financial targets and Branded Checkout growth. April 20, 2026 deadline for lead plaintiff claims.

$SLNO investors urged to join class action over undisclosed DCCR safety concerns; May 5, 2026 deadline.

Rosen Law Firm urges $MNDY investors to join class action lawsuit alleging false revenue guidance. Lead plaintiff deadline set for May 11, 2026.

Rosen Law Firm urges Kyndryl investors to join securities lawsuit alleging false financial statements and internal control deficiencies. Lead plaintiff deadline April 13, 2026.

Rosen Law Firm files securities suit against Franklin BSP Realty Trust for allegedly false statements on dividends; April 27, 2026 deadline for investors to claim.

Rosen Law Firm urges Kyndryl (KD) investors to seek legal counsel by April 13, 2026 deadline in class action alleging false financial statements and control failures.

Rosen Law Firm seeks lead plaintiffs in securities lawsuit against $KD, alleging false financial disclosures and control failures from August 2024 to February 2026.

Rosen Law Firm urges Richtech Robotics investors to join securities class action alleging false Microsoft partnership claims made January 27-29, 2026 caused shareholder damages.

NuScale Power faces securities lawsuit alleging misrepresentations about commercialization partner ENTRA1's nuclear experience. Lead plaintiff deadline: April 20, 2026.

Rosen Law Firm solicits Beyond Meat investors from Feb-Nov 2025 for class action alleging material asset value misstatements and impairment disclosure failures.

Rosen Law Firm notifies $CORT investors of securities class action alleging misrepresentation of clinical trial data for relacorilant drug and undisclosed FDA concerns.

Rosen Law Firm sued $ENPH for allegedly misleading investors on inventory management and financial prospects amid tax credit concerns.

Rosen Law Firm sues Nektar Therapeutics for alleged false statements about clinical trial protocols, seeking damages for injured investors as litigation moves forward.

DJS Law Group investigates Olema Pharmaceuticals for potential securities violations following failed Roche trial, triggering sharp stock decline.

Rosen Law Firm recruits Plug Power investors for class action alleging false DOE loan and facility construction statements. Filing deadline approaching.

uniQure faces securities lawsuit for allegedly misrepresenting Huntington's study design approval and downplaying BLA delays. Investors must act by April 13, 2026.

Oracle faces securities lawsuit alleging false AI strategy disclosures. Rosen Law Firm urges investors to join class action before deadline for undisclosed capex increases.